Showing results (1231-1240 of 1,278) with videos related to

Sort By:
Pageof 128
Psychopharmacology Bulletin|August 23, 2021
ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate TreatmentSerkan Turan, Çağatay Ermiş, Victor Pereira-Sanchez, et al.
Psychopharmacology Bulletin|August 23, 2021
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum DisorderIvano Caselli, Alessandra Gasparini, Marta Ielmini, et al.
Psychopharmacology Bulletin|August 23, 2021
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory RequirementsArif Khan, Kaysee Fahl Mar, Walter A Brown
Psychopharmacology Bulletin|March 6, 2023
Are Standardized Tests Sensitive to Early Cognitive Change in Parkinson's Disease?Travis H Turner, Daniel H Lench, Robin Adams, et al.
Psychopharmacology Bulletin|January 14, 2026
The Intersection of Gender Dysphoria (GD) and Autism Spectrum Disorder (ASD): A Case SeriesTrishna Sharma, Anuradha Reddy
Psychopharmacology Bulletin|January 14, 2026
A Pilot Study Exploring the Impact of Pro Re Nata Medication Utilization on Aggression in Forensic Psychiatric PatientsGabrielle Morgan, O Greg Deardorff, Raja Hussain, et al.
Psychopharmacology Bulletin|January 14, 2026
The Use of Lorazepam for Acute Episodes in a Patient with Kleine-Levin Syndrome: A Longitudinal Case ReportMichael Hamper, Michael Rancurello
Psychopharmacology Bulletin|January 14, 2026
Glecaprevir/Pibrentasvir for Post Traumatic Stress DisorderBradley V Watts, Jessica E Hoyt, Krista D Disano, et al.
Psychopharmacology Bulletin|January 14, 2026
Personalizing Treatment for Acute Alcoholic Hallucinosis: Clinical Utility of Integrated Pharmacogenetic Testing, Metabolic Phenotyping, and microRNA BiomarkersValentin Skryabin, Anton Masyakin, Sergei Pozdniakov, et al.
Psychopharmacology Bulletin|July 9, 2025
Genital Dysmorphia-A Valid Diagnostic Construct? and Psychopharmacological Options at HandAhmed Naguy
Pageof 128